Triple
T12544233
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc |
E299919
|
entity |
| Predicate | hasMember |
P10
|
FINISHED |
| Object | c-Myc |
E989513
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: c-Myc | Statement: [Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc, hasMember, c-Myc]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: c-Myc Context triple: [Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc, hasMember, c-Myc]
-
A.
c-Myc
chosen
c-Myc is a proto-oncogene transcription factor that regulates cell growth, proliferation, and metabolism and is frequently dysregulated in cancer.
-
B.
CDK4
CDK4 is a cyclin-dependent kinase that regulates cell cycle progression and is a key therapeutic target in certain cancers.
-
C.
CDK6
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
-
D.
Sox2
Sox2 is a key transcription factor that maintains stem cell pluripotency and self-renewal and is widely used in cellular reprogramming.
-
E.
HER2 receptor
The HER2 receptor is a cell surface protein and member of the epidermal growth factor receptor family that, when overexpressed, drives the growth of certain aggressive breast and other cancers.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6ada707008190aaec1238117c9379 |
completed | April 8, 2026, 7:33 p.m. |
| NER | Named-entity recognition | batch_69d9547d6df4819080db8415d386ed38 |
completed | April 10, 2026, 7:50 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69f65eb317148190990d47f50324a1b1 |
completed | May 2, 2026, 8:29 p.m. |
Created at: April 8, 2026, 9:57 p.m.